您当前的位置：
首页 >
文章列表页 >
Clinical observation of dapagliflozin for stable coronary heart disease combined with heart failure
更新时间：2026-02-06

    • Clinical observation of dapagliflozin for stable coronary heart disease combined with heart failure

    • “Dapagliflozin has a significant therapeutic effect on stable coronary heart disease patients with heart failure. It can improve cardiac function indicators, reduce angina attacks, and has good safety.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 11, Pages: 1375-1378(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.11.15    

      CLC： R969.4;R541

    • Received：26 December 2024，

      Revised：2025-05-15，

      Accepted：15 May 2025，

      Published：15 June 2025

    移动端阅览

  • DONG Yaohui,HU Gang,WANG Xiaohui.Clinical observation of dapagliflozin for stable coronary heart disease combined with heart failure[J].ZHONGGUO YAOFANG,2025,36(11):1375-1378. DOI： 10.6039/j.issn.1001-0408.2025.11.15.

  •  
  •  

0

Views

230

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Clinical efficacy of donafenib combined with PD-1 inhibitor and vascular intervention therapy in the treatment of unresectable hepatocellular carcinoma
Research progress on the mechanism and clinical application of the effective ingredients from Sijunzi decoction in the treatment of gastric cancer
Research progress on antibacterial activity， resistance， pharmacokinetics characteristics and clinical efficacy of omadacycline
甲状腺相关眼病患者接受激素治疗后的临床疗效及生活质量评估
前列舒宁胶囊治疗慢性前列腺炎的临床疗效观察

Related Author

CHEN Zutao
ZHANG Yu
YANG Yarong
LIU Mingming
ZHU Jinghan
SU Lan
ZHANG Ru
DANG Wenfei

Related Institution

Dept. of Infection and Hepatology， the Fourth Affiliated Hospital of Soochow University
Dept. of Infection， the First Affiliated Hospital of Soochow University
College of Pharmacy， Gansu University of Chinese Medicine
Pharmaceutical Preparation Center， Affiliated Hospital of Gansu University of Chinese Medicine
Dept. of Pharmacy， the Second Affiliated Hospital of Nanjing Medical University
0